The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients
Scholars, analysts, and companies cannot agree on what Amgen v. Sanofi means for patients, drug makers, and innovation.
Intellectual Property
-
Read more: The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients -
Read more: Don’t Be Too Alarmed by the New SCOTUS Antibody Ruling Don’t Be Too Alarmed by the New SCOTUS Antibody Ruling
SCOTUS revisits enablement, but Amgen v. Sanofi probably won’t transform patent law on its own.
-
Read more: Ketamine Is the New Viagra Ketamine Is the New Viagra
A combination of high demand and a patent monopoly has created a perfect storm of profitability for Janssen’s Spravato.
-
Read more: Making Explicit a Rights-Based Approach to Infodemic in a Public Health Emergency Making Explicit a Rights-Based Approach to Infodemic in a Public Health Emergency
Infodemic management must be an integral part of public health emergency prevention, preparedness, response, and recovery.
-
Read more: COVID-19 Showcased Failed Global Cooperation COVID-19 Showcased Failed Global Cooperation
Health emergencies happen: rights protections, solidarity should be central to response.
-
Read more: A Pseudo-Nonprofit Model for Psychedelic Clinical Trial Funding A Pseudo-Nonprofit Model for Psychedelic Clinical Trial Funding
Funding for psychedelic research may increasingly rely on nonprofit and commercial partnerships.
-
Read more: Introduction to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies Introduction to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies
In this symposium, experts around the world reflect on the recently issued Principles and Guidelines on Human Rights and Public Health Emergencies.
-
Read more: Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment
Reasonable pricing clauses are needed to ensure that American taxpayers receive a fairer return on their investment for essential therapies.
-
Read more: What the New York City Marathon Can Teach Us About Equitable Access to Vaccines What the New York City Marathon Can Teach Us About Equitable Access to Vaccines
What can the New York City Marathon teach those hoping to increase global vaccine equity? Quite a lot, it turns out.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from June 2023.
